IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme
Authors:
Open Access
- 20 February 2018
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 9 (23) , 16462-16476
Abstract
IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiformeKeywords
This publication has 70 references indexed in Scilit:
- Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activationNature, 2012
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypeNature, 2012
- IDH mutation impairs histone demethylation and results in a block to cell differentiationNature, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialThe Lancet Oncology, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and InvasionCancer Cell, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005